Hydroxychloroquine for Joint Pain in Breast Cancer

(AIMSS Trial)

NS
Overseen ByNiraj Shah, MS
Age: 18+
Sex: Any
Trial Phase: Phase 2
Sponsor: Indiana University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Prior Safety DataThis treatment has passed at least one previous human trial

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to evaluate the effectiveness of hydroxychloroquine sulfate (a type of drug commonly used to treat joint pain caused by inflammation, swelling) in reducing joint pain associated with Aromatase Inhibitor Associated Musculoskeletal Syndrome (AIMSS) for patients with breast cancer.

Who Is on the Research Team?

TB

Tarah Ballinger, MD

Principal Investigator

IUSCCC

Are You a Good Fit for This Trial?

This trial is for people with breast cancer who are experiencing joint pain and stiffness caused by taking aromatase inhibitors. Participants should not have other conditions or reasons that would prevent them from safely joining the study.

Inclusion Criteria

I have new or worse muscle or joint pain since starting AI therapy.
My blood and organ tests show normal or acceptable function.
I am able to care for myself and perform daily activities.
See 6 more

Exclusion Criteria

I have used hydroxychloroquine or chloroquine in the past 6 months.
I have a history of psoriasis.
I am taking a medication that I cannot stop or switch, which is not allowed in this study.
See 17 more

What Are the Treatments Tested in This Trial?

Interventions

  • Hydroxychloroquine Sulfate

Trial Overview

The study is testing whether hydroxychloroquine sulfate, a drug often used for arthritis, can help reduce joint pain in breast cancer patients suffering from musculoskeletal symptoms due to aromatase inhibitor therapy.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Hydroxychloroquine sulfateExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Indiana University

Lead Sponsor

Trials
1,063
Recruited
1,182,000+

100 Voices of Hope

Collaborator